MaxCyte (MXCT) Competitors $4.24 +0.10 (+2.42%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MXCT vs. SEZL, DFIN, XMTR, UPBD, GDRX, QBTS, TASK, PHR, LZ, and FVRRShould you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include Sezzle (SEZL), Donnelley Financial Solutions (DFIN), Xometry (XMTR), Upbound Group (UPBD), GoodRx (GDRX), D-Wave Quantum (QBTS), TaskUs (TASK), Phreesia (PHR), LegalZoom.com (LZ), and Fiverr International (FVRR). These companies are all part of the "business services" industry. MaxCyte vs. Sezzle Donnelley Financial Solutions Xometry Upbound Group GoodRx D-Wave Quantum TaskUs Phreesia LegalZoom.com Fiverr International MaxCyte (NASDAQ:MXCT) and Sezzle (NASDAQ:SEZL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, community ranking, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation. Do analysts prefer MXCT or SEZL? MaxCyte currently has a consensus price target of $9.50, indicating a potential upside of 124.06%. Sezzle has a consensus price target of $366.00, indicating a potential upside of 34.98%. Given MaxCyte's higher possible upside, analysts clearly believe MaxCyte is more favorable than Sezzle.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MaxCyte 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Sezzle 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more volatility and risk, MXCT or SEZL? MaxCyte has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, Sezzle has a beta of 9.23, indicating that its share price is 823% more volatile than the S&P 500. Is MXCT or SEZL more profitable? Sezzle has a net margin of 25.29% compared to MaxCyte's net margin of -78.36%. Sezzle's return on equity of 101.18% beat MaxCyte's return on equity.Company Net Margins Return on Equity Return on Assets MaxCyte-78.36% -16.00% -13.93% Sezzle 25.29%101.18%18.90% Does the media prefer MXCT or SEZL? In the previous week, Sezzle had 25 more articles in the media than MaxCyte. MarketBeat recorded 25 mentions for Sezzle and 0 mentions for MaxCyte. Sezzle's average media sentiment score of 0.35 beat MaxCyte's score of 0.00 indicating that Sezzle is being referred to more favorably in the news media. Company Overall Sentiment MaxCyte Neutral Sezzle Neutral Which has better earnings and valuation, MXCT or SEZL? Sezzle has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Sezzle, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaxCyte$41.29M10.85-$37.92M-$0.34-12.47Sezzle$221.81M6.85$7.10M$9.4028.85 Do insiders and institutionals hold more shares of MXCT or SEZL? 68.8% of MaxCyte shares are held by institutional investors. Comparatively, 2.0% of Sezzle shares are held by institutional investors. 3.0% of MaxCyte shares are held by insiders. Comparatively, 57.7% of Sezzle shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in MXCT or SEZL? MaxCyte received 2 more outperform votes than Sezzle when rated by MarketBeat users. However, 100.00% of users gave Sezzle an outperform vote while only 84.62% of users gave MaxCyte an outperform vote. CompanyUnderperformOutperformMaxCyteOutperform Votes1184.62% Underperform Votes215.38%SezzleOutperform Votes9100.00% Underperform VotesNo Votes SummarySezzle beats MaxCyte on 14 of the 19 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get MaxCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MXCT vs. The Competition Export to ExcelMetricMaxCyteCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$448.13M$4.20B$5.12B$9.07BDividend YieldN/A1.78%4.91%4.22%P/E Ratio-12.4755.3491.3417.19Price / Sales10.8547.521,116.59116.80Price / CashN/A23.6242.6437.86Price / Book1.903.144.794.78Net Income-$37.92M$139.50M$120.07M$225.60M7 Day Performance-0.93%-0.35%-1.89%-1.24%1 Month Performance22.37%3.18%11.45%3.36%1 Year Performance-6.19%14.18%30.61%16.58% MaxCyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MXCTMaxCyte2.6118 of 5 stars$4.24+2.4%$9.50+124.1%-9.6%$448.13M$41.29M-12.47143Gap DownSEZLSezzle3.9267 of 5 stars$327.15+5.9%$231.50-29.2%+1,495.1%$1.84B$159.36M35.21540Analyst ForecastAnalyst RevisionNews CoverageGap DownDFINDonnelley Financial Solutions3.1185 of 5 stars$62.70+1.1%$76.33+21.7%+0.4%$1.81B$797.20M19.391,900Insider TradeNews CoverageXMTRXometry2.0338 of 5 stars$36.51+5.0%$27.71-24.1%+30.4%$1.81B$463.41M-35.33992Analyst UpgradeNews CoverageUPBDUpbound Group4.7322 of 5 stars$32.29+1.4%$39.17+21.3%-9.9%$1.77B$3.99B21.9712,970GDRXGoodRx2.8223 of 5 stars$4.59-2.5%$8.60+87.4%-29.4%$1.75B$790.39M-157.00950Analyst ForecastQBTSD-Wave Quantum1.5905 of 5 stars$7.23+44.6%$3.71-48.7%+585.1%$1.62B$8.76M-14.263Analyst ForecastGap DownHigh Trading VolumeTASKTaskUs1.5783 of 5 stars$17.47-5.4%$17.00-2.7%+36.2%$1.56B$924.36M29.7648,200Insider TradePHRPhreesia3.8241 of 5 stars$25.64+2.8%$29.33+14.4%+15.5%$1.49B$356.30M0.001,438Insider TradeLZLegalZoom.com2.367 of 5 stars$8.12+0.6%$8.79+8.2%-29.9%$1.40B$678.84M62.081,190Positive NewsFVRRFiverr International1.7976 of 5 stars$34.47+1.2%$32.30-6.3%+17.8%$1.33B$361.38M131.04790 Related Companies and Tools Related Companies Sezzle Alternatives Donnelley Financial Solutions Alternatives Xometry Alternatives Upbound Group Alternatives GoodRx Alternatives D-Wave Quantum Alternatives TaskUs Alternatives Phreesia Alternatives LegalZoom.com Alternatives Fiverr International Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MXCT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MXCT Stock Alerts